Cape Verde vs Estonia: HIV/AIDS deaths averted by antiretroviral therapy
Cape Verde
176.27 deaths
in 2024
Estonia
217.74 deaths
in 2024
Cape Verde rank
111th
Estonia rank
108th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cape Verde
- Estonia
How they compare
Estonia currently reports 217.74 deaths against 176.27 deaths in Cape Verde, a difference of 41.47 deaths.
That makes Estonia's figure about 1.2 times Cape Verde's.
Across all 35 years both countries report, Estonia has been ahead every year.
Cape Verde ranks 111th and Estonia ranks 108th of 157 countries.
Estonia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cape Verde | Estonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 37.38 deaths | 76.25 deaths | 38.87 deaths | Estonia |
| 2010s | 125.26 deaths | 296.88 deaths | 171.63 deaths | Estonia |
| 2020s | 164.69 deaths | 240.39 deaths | 75.69 deaths | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cape Verde or Estonia?
- Estonia, at 217.74 deaths against 176.27 deaths in Cape Verde as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cape Verde and Estonia?
- 41.47 deaths, with Estonia ahead.
- How many years of comparable data are there for Cape Verde and Estonia?
- 35 years are reported by both, from 1990 to 2024.
- How do Cape Verde and Estonia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cape Verde ranks 111th and Estonia ranks 108th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.